First Pacific Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$495K Buy
10,325
+35
+0.3% +$1.5K 0.06% 130
2026
Q1
$378K Buy
10,290
+484
+5% +$22.9K 0.05% 143
2025
Q4
$499K Sell
9,806
-1,385
-12% -$70.8K 0.07% 127
2025
Q3
$621K Buy
11,191
+360
+3% +$21.1K 0.09% 115
2025
Q2
$748K Sell
10,831
-1,023
-9% -$69.6K 0.11% 102
2025
Q1
$823K Buy
+11,854
New +$979K 0.17% 71

Other funds holding NVO

First Pacific Financial's NVO Position: Q2 2026 in Review

First Pacific Financial increased its Novo Nordisk (NVO) stake by 0.34% in Q2 2026, buying an estimated $1.5K and bringing the position to 10,325 shares worth $495K. The position accounts for 0.06% of the portfolio, ranked #130.

First Pacific Financial first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $823K in Q1 2025. 479 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • First Pacific Financial held 10,325 shares of Novo Nordisk worth $495K as of Q2 2026.
  • First Pacific Financial bought 35 Novo Nordisk shares in Q2 2026, an estimated $1.5K.
  • Novo Nordisk made up 0.06% of First Pacific Financial's portfolio in Q2 2026, its #130 holding.
  • First Pacific Financial first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • First Pacific Financial's Novo Nordisk position peaked at $823K in Q1 2025.
  • 479 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.